Weight loss with a lower dose compounded semaglutide and behavioral weight management program: A real-world matched retrospective cohort study
medRxiv
- Semaglutide
- Behavioral weight management program
- GLP-1 and incretin signalling
- Area deprivation index
- Body mass index
- Humans
The paper
Noom (United States)
medRxiv · 10 Sep 2026 · Preprint, not peer-reviewed
